Patient-Centered Outcomes in 2017:

What’s New and What’s Likely Not to Change

This symposium is for everyone who helps influence their company’s investment in Patient-Centered Outcomes research, including decision-makers, strategy definition experts, and Clinical Outcome Assessment (COA) specialists

Discussion Points

Topics will include:

The landscape of COA measurement is changing. At this symposium, attendees gain a top-level understanding of the evolving Patient-Centered Outcomes environment, with Mapi’s suggestions for safe and wise decisions regarding where to invest and when to innovate.

  • What can we learn from the past year’s dynamic on COA claims?
  • What do regulators and payers expect from the pharmaceutical industry in 2016 in terms of evidence?
  • In 2016, is it still worth investing in measurement instruments such as Patient-Reported Outcomes (PRO) measures?
  • How do recent changes affect former SEALD group and the newly released FDA COA compendium?
  • What are the trends, in terms of methods (preferences), disease areas (Oncology, CNS, Rare Diseases…), and pilot compendium? Easier or harder to get a claim?

This Patient-Centered Research Workshop was presented on October 20 2016 at ISOQOL in Copenhagen. Mapi and industry experts including Benoit Arnould shared their experience and expertise with attendees from across the industry. We would love to present this workshop for your team or at your tradeshow. To find out more, contact Mapi at

Download Summary PDF

To download a PDF summary of this workshop from a recent event, please complete the following form.

At our Patient-Centered Research workshops, Mapi experts share their knowledge, insights, and experience on topics that are vital to a project’s success. As one of the leading voices in patient-centered research, Mapi is happy to share our expertise with the industry.

At Mapi, we know that research centered on people is crucial to improving world health. Our unrivaled four decades of operational expertise in generating, synthesizing, and analyzing Real World Evidence and Health Economics Outcomes Research has established Mapi Group as the industry leader and recognized innovator of Outcomes Research methodologies and sciences.

Our research solutions bridge the distance between life science companies and patients, enabling market access and navigating the complex global regulatory environment.

Our commitment runs deep. Mapi Group is the only Health Research Company with a direct-funded non-profit organization dedicated to improving Patient Outcomes and Quality of Life. The Mapi Research Trust supports thousands of independent and academic research programs every year in over 130 countries, offering free and subsidized access to Clinical Outcomes Assessments (COA), their derivatives, and translations.